Upcoming Projects (CELLTRION)
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (CELLTRION)
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (CELLTRION)
FDA’s Arthritis Advisory Committee Recommends Approval of Celltrion’s CT-P13, a Proposed Biosimilar Infliximab, for All Eligible Indications
Tickers: CELLTRION, PFE, MRK, JNJ
Occurred on: Feb 10, 2016
FDA reviewers support Celltrion's biosimilar Remicade, ahead of the Ad Comm meeting on February 9
Tickers: CELLTRION, PFE, JNJ, MRK
Occurred on: Feb 05, 2016
Strategic Initiatives (CELLTRION)
Teva (TEVA) and South Korean Celltrion Enter into Exclusive Partnership to Commercialize Biosimilars to Rituxan and Herceptin in the U.S and Canada
Tickers: TEVA, Celltrion
Announcement Date: Oct 06, 2016